Detalles de la búsqueda
1.
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.
N Engl J Med
; 384(21): 1981-1990, 2021 05 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33999548
2.
Good Clinical Practice Guidance and Pragmatic Clinical Trials: Balancing the Best of Both Worlds.
Circulation
; 133(9): 872-80, 2016 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26927005
3.
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.
Am Heart J
; 168(5): 682-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25440796
4.
Early versus delayed, provisional eptifibatide in acute coronary syndromes.
N Engl J Med
; 360(21): 2176-90, 2009 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-19332455
5.
The use of electronic health records for recruitment in clinical trials: a mixed methods analysis of the Harmony Outcomes Electronic Health Record Ancillary Study.
Trials
; 22(1): 465, 2021 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34281607
6.
Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials.
JAMA Netw Open
; 4(7): e2117963, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34297072
7.
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial.
JAMA Cardiol
; 5(5): 598-607, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32186653
8.
Facilitating translational team science: The project leader model.
J Clin Transl Sci
; 3(4): 140-146, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31660238
9.
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
Circulation
; 116(23): 2669-77, 2007 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-18025532
10.
The first call from Dad.
Am Heart J
; 162(5): 832-5, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22093198
11.
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
Am Heart J
; 152(6): 1042-50, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17161049
12.
Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Lessons from the ESPRIT study.
J Am Coll Cardiol
; 40(6): 1085-91, 2002 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-12354432
13.
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes.
Am J Cardiol
; 95(12): 1404-8, 2005 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15950560
14.
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.
JAMA
; 294(20): 2594-600, 2005 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-16304073
15.
Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial.
Am Heart J
; 143(2): 242-8, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11835026
16.
Systematic adjudication of myocardial infarction end-points in an international clinical trial.
Curr Control Trials Cardiovasc Med
; 2(4): 180-186, 2001 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-11806793
17.
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study.
Curr Control Trials Cardiovasc Med
; 2(4): 187-194, 2001 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-11806794
18.
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PCI trial.
Circ Cardiovasc Interv
; 5(3): 336-46, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22647518
19.
Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Contemp Clin Trials
; 32(2): 178-87, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21220052
20.
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).
Am J Cardiol
; 104(10): 1330-5, 2009 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19892046
Resultados
1 -
20
de 20
1
Próxima >
>>